OPEN END TURBO OPTIONSSCHEIN - BAYER | Market Closed - Börse Stuttgart 09:56:42 2024-05-15 am EDT | ||
| 5.48 EUR | +0.18% |
|
| Current month | -3.52% | ||
| 1 month | -4.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 24-05-15 | 5.48 | +0.18% |
| 24-05-14 | 5.47 | 0.00% |
| 24-05-13 | 5.47 | -0.73% |
| 24-05-10 | 5.51 | -0.72% |
| 24-05-09 | 5.55 | -0.72% |
Delayed Quote Börse Stuttgart
Last update May 15, 2024 at 09:56 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BAYER AG |
| Issuer | J.P. Morgan |
| WKN | JA76PX |
| ISIN | DE000JA76PX6 |
| Date issued | 2022-05-30 |
| Strike | 84.19 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.3 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.88 € |
|---|---|
| Lowest since issue | 2.16 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
29.32
EUR
Average target price
36.9
EUR
Spread / Average Target
+25.85%
- Stock Market
- Certificates
- Certificat
